Display options
Cite
De Leeuw I. Atherogenic profiles in insulin-dependent diabetic patients and their treatment. Eur J Epidemiol. 1992;8:125-8doi: 10.1007/BF00145363.
De Leeuw, I. (1992). Atherogenic profiles in insulin-dependent diabetic patients and their treatment. European journal of epidemiology, 8125-8. https://doi.org/10.1007/BF00145363
De Leeuw, I. "Atherogenic profiles in insulin-dependent diabetic patients and their treatment." European journal of epidemiology vol. 8 (1992): 125-8. doi: https://doi.org/10.1007/BF00145363
De Leeuw I. Atherogenic profiles in insulin-dependent diabetic patients and their treatment. Eur J Epidemiol. 1992 May;8:125-8. doi: 10.1007/BF00145363. PMID: 1505649.
Copy Download .nbib Format: NLM
Share it on

Eur J Epidemiol. 1992 May;8:125-8. doi: 10.1007/BF00145363.

Atherogenic profiles in insulin-dependent diabetic patients and their treatment.

European journal of epidemiology

I De Leeuw

Affiliations

  1. Department of Endocrinology-Metabolism and Clinical Nutrition, University of Antwerp 1, Belgium.

PMID: 1505649 DOI: 10.1007/BF00145363

Abstract

Longitudinal studies have shown a large excess of cardiovascular mortality in insulin-dependent diabetic patients (IDDM) as compared to non-diabetic controls. Although diabetes appears to be an independent cardiovascular risk factor, increases in total and LDL-cholesterol together with a decrease of HDL-cholesterol are more pronounced in diabetics with cardiovascular disease. The general opinion, however, derived from a large number of cross-sectional studies, is that in well-controlled IDDM lipoprotein abnormalities are modest and only slightly different from matched non-diabetic controls. Most of the studies, however, used absolute criteria based on consensus statements and do not take the internal relations of the lipoproteins into account. When atherogenic indices (such as the relationship between total cholesterol and HDL-cholesterol or the Apo A1/apo B quotient) are used, 20 to 30% of an IDDM population considered to be in clinically acceptable control have to be considered pathological. This observation is even more important since the recent Diabetes Control and Complications Trial has shown that, especially in the younger group of patients, significantly higher total cholesterol and triglycerides and lower HDL-cholesterol were observed. Especially in these patients can diet and drug intervention be the most useful in the prevention of cardiovascular disease. These data are consistent with the fact that more sophisticated techniques have previously shown atherogenic changes in the composition of the VLDL-particles and lipoprotein enrichment in apo B. Since these techniques are not easily available in the clinic one has to refer to more classical techniques and the use of above mentioned atherogenic profiles to decide treatment.

Similar articles

Cited by

References

  1. Diabetes. 1980 Dec;29(12):1001-5 - PubMed
  2. Diabetes Care. 1988 Feb;11(2):129-42 - PubMed
  3. Metabolism. 1989 May;38(5):404-9 - PubMed
  4. Clin Chem. 1989 May;35(5):813-6 - PubMed
  5. N Engl J Med. 1980 Mar 20;302(12):650-4 - PubMed
  6. Diabetes. 1981 Feb;30(2):132-8 - PubMed
  7. Am J Dis Child. 1976 Oct;130(10):1113-7 - PubMed
  8. Am J Cardiol. 1987 Apr 1;59(8):750-5 - PubMed
  9. Diabetologia. 1981 Sep;21(3):216-23 - PubMed
  10. Diabetes. 1989 Mar;38(3):364-72 - PubMed
  11. Kidney Int. 1988 Jun;33(6):1160-8 - PubMed
  12. Ann Intern Med. 1981 Oct;95(4):426-31 - PubMed
  13. J Lipid Res. 1983 May;24(5):588-95 - PubMed
  14. Diabetes. 1978 Nov;27(11):1078-86 - PubMed
  15. Metabolism. 1971 Nov;20(11):1031-5 - PubMed
  16. N Engl J Med. 1986 Mar 20;314(12):745-8 - PubMed
  17. Diabet Med. 1990 May;7(4):292-8 - PubMed
  18. Diabetes Care. 1983 Jul-Aug;6(4):361-9 - PubMed
  19. J Clin Invest. 1986 Feb;77(2):641-4 - PubMed
  20. Am J Med. 1987 Aug;83(2):243-8 - PubMed
  21. Metabolism. 1985 Jun;34(6):559-66 - PubMed
  22. J Lipid Res. 1982 Jan;23(1):171-82 - PubMed
  23. Metabolism. 1985 Jul;34(7):675-9 - PubMed
  24. N Engl J Med. 1988 Jan 14;318(2):81-6 - PubMed
  25. Diabetes Care. 1981 Jan-Feb;4(1):76-80 - PubMed
  26. Diabetes Care. 1989 May;12(5):332-6 - PubMed

Substances

MeSH terms

Publication Types

LinkOut - more resources